Estradiol levels on HRT: what the number means, in pg/mL and pmol/L

There is no single target, but some numbers are useful. See where your result sits in both units, how a patch, gel or tablet changes the reading, which dose band you are on, and the few times a blood test changes the plan.

Reviewed by LifeFrom’s medical AIPublished November 20, 2026 · 10 min
Ask AI about this pageChatGPTClaudePerplexity
The distinctions
  1. 01
    The estradiol test checks absorption; symptoms judge the dose

    Whether a dose is right is judged by how you feel and by side effects, which is why NICE advises reviewing HRT at 3 months and then at least yearly, and sets no blood level to aim for. A blood estradiol level is good at one narrower job: showing whether a patch or gel is being absorbed when symptoms persist on a dose that should be enough. Ask what a result would change before you order one.

An estradiol result on HRT shows how much hormone reached your blood at the moment of the draw. It cannot show whether your dose suits you, which is why many prescribers rarely order one. On a patch or gel, half the women in a large real-world study read between about 55 and 176 pg/mL (200 to 650 pmol/L), and how you feel still decides the dose 12.

01Reading the number

What should my estradiol be on HRT?

The test measures estradiol (E2, spelled oestradiol on UK reports), the main estrogen the ovaries make before menopause and the hormone in most patches, gels and tablets. US labs report it in pg/mL and UK labs in pmol/L, so the same level looks almost four times bigger on a UK report; multiply pg/mL by 3.671 to convert. The units guide covers why labs differ. Most reference points in the table come from a large real-world study of 1,508 women on transdermal (through the skin) estradiol 2.

Estradiol (pg/mL)Estradiol (pmol/L)What it usually means on HRT
Under 30Under 110Typical of untreated postmenopause. On HRT: a low-dose patch, a patch or gel that is not being absorbed, an oral or conjugated estrogen the test reads poorly, or an immunoassay that is inaccurate at low levels 4
30 to 54110 to 199Under the 200 pmol/L line the 2025 study used to mark a low level on patch, gel or spray 2
55200That low line 2
60220Just above the low line; often adequate when symptoms are controlled
97355The median in the 2025 study 2
100367The bottom of the feminising HRT target 3
176646The top of the middle half in the 2025 study; a quarter of women read higher 2
200734The top of the feminising HRT target 3

None of these lines is a guideline target: NICE sets the dose by symptom relief and side effects 1. A level under 200 pmol/L matters most when hot flashes, night sweats or poor sleep persist on a dose that should be enough. A quarter of the women in the study read above 646 pmol/L 2, so a higher level matters mainly when side effects appear or the sample may be contaminated.

Example: estradiol on a 50 mcg patchpg/mL

60 pg/mLjust above the low line · about 220 pmol/L
Typical untreated postmenopause (approx.)0–30Under the 200 pmol/L line30–55Middle half of women on patch or gel55–176Upper quarter; no agreed ceiling176–250
An estradiol of 60 pg/mL on a standard patch sits just above the low line. When symptoms are controlled, a level like this is usually read as the dose working; if they persist, bring this result to your prescriber.
Cutoffs: under about 30 pg/mL is approximate, from typical lab ranges for untreated postmenopause; 55 pg/mL (200 pmol/L) is the low line, and 55 to 176 pg/mL (198 to 646 pmol/L) the middle half, of 1,508 women on patch, gel or spray in Glynne et al., Menopause 2025. No guideline sets a target or a ceiling for menopausal HRT. Example value only.

Why your prescriber goes by symptoms first

NICE NG23 asks prescribers to review HRT about 3 months after starting or changing it and then at least once a year, and to judge it on symptom relief and side effects 1. Four facts sit behind that advice.

  • A single draw is a snapshot. Gel peaks a few hours after applying, and patch levels drift across the days a patch is worn, which is why a trend beats a single reading.
  • In perimenopause the ovaries still release estradiol in bursts, and the test cannot separate your own estradiol from the patch's.
  • Tissues respond differently, so two women at 300 pmol/L can feel quite different.
  • No blood level has been shown to guarantee symptom relief or protection for bone, which a DEXA scan measures directly.

The spread between people on the same treatment is wide. In the Glynne study the median was 355 pmol/L, the middle half ran from 198 to 646 pmol/L, and the middle 95% spanned about 55 to 2,050 pmol/L; about 1 in 4 women on the highest licensed dose read under 200 pmol/L 2. That spread is why the test still has a job: showing whether the estrogen is getting in when symptoms say it may not be.

Measurement of serum estradiol can be helpful to identify women who may benefit from an off-label dose.Glynne et al., Menopause 2025 2

02Your route, your dose, your timing

Patch, gel, tablet or implant: how your route changes the result

The route of your HRT decides how much an estradiol result can show. Estradiol absorbed through the skin enters the blood unchanged. Estradiol swallowed as a tablet passes through the gut and liver first, where much of it becomes estrone (E1, a weaker estrogen), so an oral dose looks smaller on an estradiol test than its total estrogen effect 8.

RouteDoes estradiol reflect the dose?When to drawWatch-outs
PatchYes, fairly steadilyAny day; note which day of the patch's wear it isLevels can dip toward change day; patch users had about 1.5 times the odds of a level under 200 pmol/L 2
Gel or sprayYes, but moves with time since applyingThe same number of hours after applying each timeNever sample from the arm or hand the gel goes on; levels vary more between people than on patches 2
Oral estradiol tabletPartly; estrone runs several times higher than estradiol 8The same time after the tablet each timeEstradiol under-reads the total estrogen
Conjugated estrogens or tiboloneBarelyRarely usefulDifferent molecules; an estradiol test misses most of them
Implant (pellet)YesBefore the next implant is dueLevels can stack with repeat implants
Injection (mostly feminising HRT)Yes, with peaks and troughsNote the days since the shot; clinics often draw at the trough or midpointA draw in the first few days after a shot catches the peak
Low-dose vaginal estrogenNo meaningful rise in the blood 9No test neededBlood estradiol stays in the postmenopausal range 9

For blood tests, patch and gel users get the most readable estradiol result, and oral users the least. If you used a home kit, the finger-prick guide explains why gel on the pricked hand can read falsely high. Each route's benefits and risks, including clot risk, sit on the HRT guide.

Is my dose low, standard or high?

The British Menopause Society's prescribing tool sorts estradiol doses for women of usual menopause age (45 to 55) into low, medium and high bands that roughly match across routes 7. A 0.05 mg patch (50 mcg a day) is a medium, or standard, dose rather than a low one, and a 0.5 mg estradiol tablet is a low dose. Bands describe a prescription; do not move between them without your prescriber.

BandPatch (per day)Oestrogel (pumps a day)Oral estradiol (per day)
Low25, 30 or 37.5 mcg10.5 mg
Medium (standard)40, 50 or 75 mcg2 to 31 to 2 mg
High100 mcg43 mg, outside the licence

The BMS notes that absorption varies so much between women that these equivalents cannot be precise, and keeps high and above-licence doses for individual cases after a full discussion 7. US gels such as Divigel, and the Evamist spray, are dosed differently; ask your prescriber which band your dose matches. The table also leaves out women with premature ovarian insufficiency, menopause before 40, who usually need more estrogen than women in their fifties.

A woman with POI at 30 is replacing estrogen her ovaries would normally make for another 20 years, and going without it is linked to a shorter life, largely through heart disease.

LifeFrom, premature ovarian insufficiency

When a blood test on HRT is worth doing

Before ordering an estradiol test on HRT, ask what the result would change. These situations give a result that someone can act on.

Worth testing

  • Symptoms persist on a medium or high patch or gel dose, and absorption is in question
  • A baseline at the 3-month review after starting or changing dose, to compare against if symptoms return
  • An earlier result that looked odd and needs repeating under clean conditions
  • Before a repeat implant, so levels do not stack
  • Premature ovarian insufficiency, or specialist care for osteoporosis
  • Feminising HRT, where testing is routine 3

Rarely worth testing

  • You feel well and want to push the number higher
  • You want to know whether you are still in perimenopause while taking HRT; the test cannot tell
  • You take conjugated estrogens, tibolone or low-dose vaginal estrogen, which an estradiol test does not reflect

How to time the test so the number means something

An estradiol result on HRT is only comparable with the next one if both were drawn the same way. These six habits make a result readable; the general blood test prep guide covers fasting and time of day.

  1. 1Wait for the dose to settleTest at least 6 to 8 weeks after starting or changing a dose; the 3-month review NICE recommends is a natural point 1.
  2. 2Keep your routineTake or apply HRT as usual on the day, unless your prescriber or clinic has asked you to time the draw a particular way.
  3. 3Match the timing every timeSame hours since your gel or tablet, same day of patch wear, same lab and, where possible, the same method.
  4. 4Protect the sample from your gelGel, spray or cream on the hand or arm used for the sample can give a falsely high result. Apply HRT on the other side, or have blood taken from a vein in the other arm.
  5. 5Pause biotin if your prescriber agreesHigh-dose biotin can skew some hormone tests in either direction. The biotin guide covers how long before a test it matters.
  6. 6Ask about the method at low levelsAt postmenopausal levels, standard immunoassays (the antibody-based tests most labs run) are inaccurate, and mass spectrometry (LC-MS/MS) is the more reliable method 4. Write your product, dose and timing on the request form.
Free, no accountRead your blood testGot an estradiol result back on HRT and want every line of the report explained? Read it free.Read my results
03The rest of the panel

The other numbers on an HRT panel

FSH (follicle stimulating hormone, the pituitary signal to the ovaries) often stays high on transdermal HRT and does not guide the dose. It belongs to diagnosis, and NICE limits it even there: most women over 45 with typical symptoms need no blood test to diagnose menopause, and an FSH test is kept for women aged 40 to 45 with symptoms and for women under 40 when premature ovarian insufficiency is suspected 1.

MarkerUseful on HRT?What to know
FSHNot as a dose guideOften stays high on patch or gel; used for diagnosis, not monitoring 1
ProgesteroneNoMicronised progesterone (body-identical progesterone, such as Utrogestan or Prometrium) swings through the day. Protection for the womb comes from the right progestogen dose (the progesterone-type hormone that protects the womb lining), checked by your bleeding pattern; see the bleeding signs below
Total testosteroneOnly if testosterone is addedChecked before starting and about 3 to 6 weeks after, to stay within the premenopausal female range 5
SHBGMainly on tabletsOral estrogen raises it, leaving less free testosterone
TSHIf you take levothyroxineCan rise within about 12 weeks of starting oral estrogen 6
TriglyceridesMainly on tabletsRise on oral estrogen; a high level is one reason prescribers favour a patch or gel

Estrogen tablets pass through the liver first, so they change blood results far more than patches or gels do.

LifeFrom, HRT guide

Testosterone is sometimes added after menopause for low sexual desire that causes distress (hypoactive sexual desire disorder), a decision for a specialist or prescriber 5; the low libido page covers other causes. Because oral estrogen raises SHBG (sex hormone binding globulin, the protein that carries testosterone), a woman on tablets can have a normal total testosterone and still little free hormone; the free testosterone calculator estimates it from both numbers.

If you take levothyroxine, oral estrogen raises the protein that carries thyroid hormone. In one study TSH rose within about 12 weeks of starting it, and some women needed a higher thyroid dose 6, so prescribers often recheck TSH about 12 weeks after oral estrogen is started. The thyroid panel guide shows how to read the change.

The female hormone panel guide reads these markers for women not on HRT.

Estradiol levels on feminising HRT

Feminising HRT for trans women and transfeminine people (often searched as MTF HRT) works to explicit numbers. The Endocrine Society's 2017 guideline suggests estradiol of 100 to 200 pg/mL (about 367 to 734 pmol/L) with testosterone under 50 ng/dL (about 1.7 nmol/L), checked every 3 months in the first year and then once or twice a year 3. The guideline frames the estradiol figure as a ceiling as well as a goal.

Serum estradiol should not exceed the peak physiologic range.

Hembree et al., Endocrine Society guideline, 2017 3
MarkerTarget on feminising HRTOther unitHow often
Estradiol100 to 200 pg/mLAbout 367 to 734 pmol/LEvery 3 months in year one, then 1 to 2 times a year 3
Total testosteroneUnder 50 ng/dLAbout 1.7 nmol/LSame schedule 3

On spironolactone, the guideline adds potassium checks every 3 months in year one and then yearly 3. Lab reports may flag estradiol and testosterone against the range for the sex on your record, so a flag may reflect the wrong reference range; ask your clinic which range they read your result against. On injections, note the days since the shot, because a draw at the peak and a draw at the trough can differ several-fold.

CalculatorTestosterone converterConvert a testosterone result between ng/dL and nmol/L to check it against the 50 ng/dL target.Work it out

Results that need a word with your prescriber

  • A low estradiol on a medium or high patch or gel dose, with symptoms still present. The usual next questions are about absorption, how and where the product is applied, and whether a different route suits you better.
  • A very high estradiol. First rule out gel on the sampling hand or arm and a draw soon after applying; then breast tenderness, bloating or headaches point to a dose review. A sudden, severe or unusual headache, or one with changes in vision or speech, is not a dose question: get emergency care. Repeat implants can also stack levels high.
  • Unscheduled bleeding past the first 6 months of continuous combined HRT (estrogen and progestogen every day, meant to give no bleeds), or a change in your usual bleed on sequential HRT (progestogen for part of each month, giving a monthly bleed). This needs checking whatever the blood numbers say.
  • A rising TSH after starting oral estrogen if you take levothyroxine 6.

Before starting HRT, the perimenopause check sums up how closely your symptoms match the usual perimenopause pattern, as a starting point for a conversation with your doctor; an estradiol or FSH result cannot answer that question once treatment has begun. For most people on menopausal HRT, how you feel at the 3-month review remains the measure that decides the dose, and an estradiol result is the tool for checking that a patch or gel is getting in. For the wider picture on symptoms, tests and treatment, see menopause support.

Free, no accountDrop in your lab report and see every marker explained in plain words, placed on the body, against your lab's range. It's read on your device: nothing is uploaded and nothing is kept.
Citations
  1. National Institute for Health and Care Excellence. Menopause: identification and management (NG23). 2015, updated 2024
  2. Glynne S, Reisel D, Kamal A, et al. The range and variation in serum estradiol concentration in perimenopausal and postmenopausal women treated with transdermal estradiol in a real-world setting: a cross-sectional study. Menopause 2025;32(2):103-111
  3. Hembree WC, Cohen-Kettenis PT, Gooren L, et al. Endocrine treatment of gender-dysphoric/gender-incongruent persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2017;102(11):3869-3903
  4. Rosner W, Hankinson SE, Sluss PM, Vesper HW, Wierman ME. Challenges to the measurement of estradiol: an Endocrine Society position statement. J Clin Endocrinol Metab 2013;98(4):1376-1387
  5. Davis SR, Baber R, Panay N, et al. Global consensus position statement on the use of testosterone therapy for women. J Clin Endocrinol Metab 2019;104(10):4660-4666
  6. Arafah BM. Increased need for thyroxine in women with hypothyroidism during estrogen therapy. N Engl J Med 2001;344(23):1743-1749
  7. British Menopause Society. HRT: practical prescribing. BMS Tool for Clinicians. Reviewed May 2026, amended August 2026
  8. Kuhl H. Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric 2005;8 Suppl 1:3-63
  9. The North American Menopause Society. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause 2020;27(9):976-992

Educational context only, not medical advice or a diagnosis. Always discuss your results with a clinician.